On March 11th 2021, Biolyse Pharma (“Biolyse”) issued a statement publicly indicating their capacity to manufacture a COVID-19 vaccine and their intent to apply for a compulsory license in Canada. Biolyse is a Canadian manufacturer of cancer drugs based out… Continue Reading
On Wednesday, 29 June 2022, the Core Group (Brazil, China, Egypt, India, Indonesia, Senegal, South Africa, Thailand) tabled a resolution on “Access to medicines, vaccines, and other health products in the context of the right of everyone to the enjoyment… Continue Reading
On 24 May 2022, I delivered the following constituency statement on behalf of Knowledge Ecology International, Health Action International, Oxfam, and Public Services International on the following topic: “16.2 – Strengthening WHO preparedness for and response to health emergencies” at… Continue Reading
At around 10 PM on Friday evening, 20 May 2022, member states of the World Health Organization (WHO) negotiating on a resolution titled, Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination,… Continue Reading
The announcement was made by President Biden at the Global COVID-19 Pandemic Summit. KEI Statement on the NIH/C-TAP licenses Following an earlier promise from HHS Secretary Xavier Becerra, the NIH has entered into two licenses with the WHO COVID-19 Technology… Continue Reading
On Wednesday May 11, 2022, the National Institutes of Health (NIH) was asked about Xtandi and march-in rights during a Congressional hearing. The House Appropriations Committee held a hearing on the FY2023 Budget Request for the NIH, and Representative Mark… Continue Reading
A legal brief filed by Moderna, Inc. (“Moderna”) on May 6, 2022 argues that 28 U.S.C. § 1498(a) immunizes the company from liability if it infringes on any third-party patents involved in the manufacture of its Covid-19 vaccine (marketed as… Continue Reading
On April 28, 2022, Knowledge Ecology International (KEI) provided comments on the latest National Institutes of Health (NIH) Federal Register notice concerning licensing, the “Prospective Grant of an Exclusive Patent License: Development of Diagnostic for Imaging and Early Detection of… Continue Reading
Last week, Professor Brook Baker filed an Amicus Brief responding to four of the arguments made by Pfizer against the compulsory license requested by KEI in the Dominican Republic to allow the distribution of the generic version of Paxlovid. His… Continue Reading
On 22 March 2022, the World Health Organization (WHO) published a detailed timeline in relation to meetings of the Intergovernmental Negotiating Body (INB) to draft and negotiate a WHO convention, agreement or other international instrument on pandemic prevention, preparedness and… Continue Reading
As reported by Politico on 26 January 2022, at the 150th session of the World Health Organization’s Executive Board, the United Kingdom of Great Britain and Northern Ireland made a “surprise proposal…for a new World Health Organization resolution on clinical… Continue Reading